Brief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
27/05/2026 11:37
BRIEF-Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026 May 27 (Reuters) - Medicamen Biotech Ltd MEBI.NS:
RECOMMENDS FINAL DIVIDEND OF 1 RUPEE PER SHARE FOR FY ENDED MARCH 31, 2026
Source text: ID:nBSEbC2g0R
Further company coverage: MEBI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma